![Impurity C of Alfacalcidol - CAS# 82266-85-1 Catalog No.:M10448-10 5]decan-8-yl)-1H-pyrazolo[3](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M10448_1621561896.gif?v=1742877657)
Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
5]decan-8-yl)-1H-pyrazolo[3
5-difluoro-4-((3-methyl-1H-pyrrolo[2
Formula: C31H36F6N6O2
ClH/c30-21-8-4-20(5-9-21)28-26(24-13-10-22(31)18-25(24)34-28)27(32)19-6-11-23(12-7-19)33-17-16-29-14-2-1-3-15-29
Niraparib is currently in Phase 3 clinical trials for ovarian cancer and BRCA+ breast cancer
Impurity C of Alfacalcidol - CAS# 82266-85-1 Catalog No.:M10448-10 5]decan-8-yl)-1H-pyrazolo[3Impurity of Alfacalcidol. Alfacalcidol (1 hydroxycholecalciferol; Alpha D3; 1. alpha. Hydroxyvitamin D3) is a non selective VDR activator medication. IC50 value: Target: VDR activatorAlfacalcidol (1 hydroxycholecalciferol; Alpha D3; 1. alpha. Hydroxyvitamin D3) improves mechanical bone strength and bone mass; suppresses osteoclastic bone resorption in vivo. Product information CAS Number: 82266 85 1 Molecular Weight: 575. 78 Formula: C35H49N3O4